Join
Live feed
·
PRReleasevia Quantisnow
Belite Bio Inc logo

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

ByQuantisnow·Wall Street's wire, on your screen.
BLTE· Belite Bio Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLTE (Belite Bio Inc) and more on Quantisnow.